TULIEVE DIN 02505401
Status: Dormant
Holder: NORBROOK LABORATORIES LTD.
Health Canada record
| Active ingredient(s) | TULATHROMYCIN 100 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intramuscular; Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 08-Apr-2021 |
|---|
| Current status date | 08-Jul-2025 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Norbrook Laboratories Limited — licence , not currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TULATHROMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02532859 | AROVYN | INTERVET CANADA CORP | Solution | TULATHROMYCIN 100 MG | Approved |
| 02285452 | DRAXXIN | ZOETIS CANADA INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02430711 | DRAXXIN 25 | ZOETIS CANADA INC | Solution | TULATHROMYCIN 25 MG | Marketed |
| 02516683 | DRAXXIN KP | ZOETIS CANADA INC | Solution | TULATHROMYCIN 100 MG; KETOPROFEN 120 MG | Marketed |
| 02516500 | INCREXXA | ELANCO CANADA LIMITED | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02508990 | LYDAXX | VETOQUINOL N A INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02544229 | MACROSYN | BIMEDA-MTC ANIMAL HEALTH INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02536013 | TULAJECT | ALIVIRA ANIMAL HEALTH LIMITED | Solution | TULATHROMYCIN 100 MG | Approved |
| 02502151 | TULAVEN | CEVA ANIMAL HEALTH INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02530155 | TULINOVET | MODERN VETERINARY THERAPEUTICS LLC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02502879 | TULISSIN | VIRBAC AH, INC. | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02536277 | TULISSIN 25 | VIRBAC AH, INC. | Solution | TULATHROMYCIN 25 MG | Approved |
| 02560348 | VACASAN | PARNELL TECHNOLOGIES PTY LTD | Solution | TULATHROMYCIN 100 MG | Approved |
| 02518236 | REXXOLIDE | DECHRA REGULATORY BV | Solution | TULATHROMYCIN 100 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 31451 | 2023-08-21 | Supplement to an Abbreviated New Drug Submission (SANDS) | Administrative - Change in brand name |
| 24757 | 2020-12-07 | Supplement to an Abbreviated New Drug Submission (SANDS) | CHANGE IN BRAND NAME |
| 24262 | 2020-09-21 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for TULIEVE
How to read a Canadian DIN record